Skip to main content

Advertisement

SpringerLink
Log in

Milrinone Via Lumbar Subarachnoid Catheter for Vasospasm After Aneurysmal Subarachnoid Hemorrhage

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction

Delayed ischemic neurological deficit (DIND) due to symptomatic vasospasm is a major cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). The aim of this study was to elucidate the safety and feasibility of intrathecal milrinone infusion via lumber subarachnoid catheter for prevention of DIND after aSAH.

Methods

We diagnosed 425 consecutive patients with aSAH who received clipping or coil embolization within 48 h after arrival. Patients with the evidence of vasospasm on CT angiography (CTA) received the milrinone therapy via lumbar subarachnoid catheter. DIND, delayed cerebral infarction (DCI), and modified Rankin scale at 3 months after SAH were used for the assessment of outcome.

Results

Of 425 patients, 170 patients (40.0 %) with CTA-proven vasospasm received the milrinone therapy. DIND was observed in 68 patients (16.0 %), DCI in 30 patients (7.1 %), and the overall mortality was 7.2 %. In patients with WFNS grade IV and V aSAH, 26 out of 145 patients (17.9 %) were presented with DIND, 12 (8.3 %) with DCI, and the mortality was 16.0 %. No major complication related to the milrinone injection was observed.

Conclusion

Intrathecal milrinone injection via lumbar catheter was safe and feasible, and further randomized prospective studies are needed to confirm the effectiveness of this regimen in the patients with SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S. Prediction of mortality by hematological parameters on admission in patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2011;51:745–8.

    Article  Google Scholar 

  2. Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schürer L, Lumenta CB. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care. 2010;12:346–51.

    Article  CAS  PubMed  Google Scholar 

  3. Liu JK, Couldwell WT. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2005;2:124–32.

    Article  PubMed  Google Scholar 

  4. Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–52.

    Article  CAS  PubMed  Google Scholar 

  5. Kimball MM, Velat GJ, Hoh BL. Participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care. 2011;15:336–41.

    Article  PubMed  Google Scholar 

  6. Santillan A, Knopman J, Zink W, Patsalides A, Gobin YP. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2011;69:95–101.

    Article  PubMed  Google Scholar 

  7. Shirao S, Yoneda H, Kunitsugu I, et al. Preoperative prediction of outcome in 283 poor-grade patients with subarachnoid hemorrhage: a project of the Chugoku-Shikoku Division of the Japan Neurosurgical Society. Cerebrovasc Dis. 2010;30:105–13.

    Article  PubMed  Google Scholar 

  8. Khajavi K, Ayzman I, Shearer D, et al. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40:354–62.

    Article  CAS  PubMed  Google Scholar 

  9. Nishibuchi M, Ono S, Iseda K, Manabe H, Hishikawa T, Date I. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. Neurosurgery. 2010;66:158–64.

    Article  Google Scholar 

  10. Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48:723–8.

    CAS  PubMed  Google Scholar 

  11. Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–8.

    Article  PubMed  Google Scholar 

  12. Goto Y, Yamagata S. Differences in outcome in patients with poor grade subarachnoid hemorrhage (WFNS grade IV and V): according to the perioperative management against vasospasm. No Shinkei Geka. 2004;32:579–84.

    PubMed  Google Scholar 

  13. Omar MA, Mohd Haspani MS. The risk factors of external ventricular drainage-related infection at hospital Kuala Lumpur: an observational study. Malays J Med Sci. 2010;17:48–54.

    PubMed Central  PubMed  Google Scholar 

  14. Arakawa Y, Kikuta K, Hojo M, et al. Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage of WFNS grade IV or V. Neurol Med Chir (Tokyo). 2004;44:393–400.

    Article  Google Scholar 

  15. Shirao S, Yoneda H, Ishihara H, Kajiwara K, Suzuki M; Survey Study Members of Japan Neurosurgical Society. A proposed definition of symptomatic vasospasm based on treatment of cerebral vasospasm after subarachnoid hemorrhage in Japan: consensus 2009, a project of the 25 Spasm Symposium. Surg Neurol Int. 2011;2:74.

  16. Bracard S, Lebedinsky A, Anxionnat R, et al. Endovascular treatment of Hunt and Hess grade IV and V aneurysm. Am J Neuroradiol. 2002;23:953–7.

    PubMed  Google Scholar 

  17. Taylor CJ, Robertson F, Brealey D, et al. Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care. Neurocrit Care. 2011;14:341–7.

    Article  PubMed  Google Scholar 

  18. Weir RU, Marcellus ML, Do HM, Steinberg GK, Marks MP. Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. Am J Neuroradiol. 2003;24:585–90.

    PubMed  Google Scholar 

  19. Romero CM, Morales D, Reccius A, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11:165–71.

    Article  CAS  PubMed  Google Scholar 

  20. Nozaki K. Intraarterial infusion therapy for cerebral vasospasm: promising but preliminary. World Neurosurg. 2012;78:223–5.

    Article  PubMed  Google Scholar 

  21. Lannes M, Teitelbaum J, del Pilar Cortés M, Cardoso M, Angle M. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol. Neurocrit Care. 2012;16:354–62.

  22. Taki W, Sakai N, Suzuki H; PRESAT Group. Determinants of poor outcome after aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan. World Neurosurg. 2011;76:437–45.

  23. Molyneux A, Kerr R, Stratton I, International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.

    Article  PubMed  Google Scholar 

  24. Nieuwkamp DJ, Vaartjes I, Algra A, Bots ML, Rinkel GJ. Age- and gender-specific time trend in risk of death of patients admitted with aneurysmal subarachnoid hemorrhage in the Netherlands. Int J Stroke. 2013;8 Suppl A100:90–4.

  25. Treggiari MM; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15:329–35.

  26. Al-Tamimi YZ, Bhargava D, Feltbower RG, et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 2012;43:677–82.

    Article  PubMed  Google Scholar 

  27. Liu GJ, Wang ZJ, Wang YF, et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J of Clin Pharmacol. 2012;68:131–9.

    Article  CAS  Google Scholar 

  28. Sadamasa N, Yoshida K, Narumi O, et al. Trends in mortality rates for subarachnoid hemorrhage, from 1999 through 2008: single center experience. No Shinkei Geka. 2010;38:811–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

None.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki City, Okayama, 710-8602, Japan

    Nobutake Sadamasa, Kazumichi Yoshida, Osamu Narumi, Masaki Chin & Sen Yamagata

Authors
  1. Nobutake Sadamasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazumichi Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osamu Narumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaki Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sen Yamagata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobutake Sadamasa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadamasa, N., Yoshida, K., Narumi, O. et al. Milrinone Via Lumbar Subarachnoid Catheter for Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 21, 470–475 (2014). https://doi.org/10.1007/s12028-014-9996-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-014-9996-5

Keywords

Search

Navigation